Regeneron
Christos Kyratsous, PhD, joined Regeneron in 2011 and is the Senior Vice President of Research. He leads the development of our next-generation genetic therapeutics platforms and is the head of the Infectious Diseases Therapeutic Focus Area. Dr. Kyratsous previously worked at the Howard Hughes Medical Institute and was a postdoctoral fellow at New York University. He received his BS from the Aristotle University of Thessaloniki in Greece and then received his PhD in Microbiology at Columbia University.
This person is not in any offices
Regeneron
124 followers
Regeneron Pharmaceuticals is focused on the development of pharmaceutical products for the treatment of serious medical conditions.